Citation Impact
Citing Papers
Phase II Study of Dose-Adjusted EPOCH and Rituximab in Untreated Diffuse Large B-Cell Lymphoma With Analysis of Germinal Center and Post-Germinal Center Biomarkers
2008
New prognostic factors in nasopharyngeal carcinoma: Tumor angiogenesis and C-erbB2 expression
1996
The ratio of CD8 + lymphocytes to tumor-infiltrating suppressive FOXP3 + effector regulatory T cells is associated with treatment response in invasive breast cancer
2022 StandoutNobel
The BCL6‐associated transcriptional co‐repressor, MTA3, is selectively expressed by germinal centre B cells and lymphomas of putative germinal centre derivation
2007
Rearrangements of bcl-6, bcl-2, c-myc and 6q deletion in B-diffuse large-cell lymphoma: Clinical relevance in 71 patients
1998
The Oncogenic Cysteine-rich LIM domain protein Rbtn2 is essential for erythroid development
1994 StandoutNobel
Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study
2019 Standout
Annexin V-Affinity assay: A review on an apoptosis detection system based on phosphatidylserine exposure
1998 Standout
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours
2010 Standout
A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor Types
1994 StandoutScience
Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience
2002 Standout
Hematopoietic Stem-Cell Transplantation
2006 Standout
Death and anti-death: tumour resistance to apoptosis
2002 Standout
Deletions of Interferon Genes in Acute Lymphoblastic Leukemia
1990
Thioredoxin, a putative oncogene product,is overexpressed in gastric carcinoma and associated with increased proliferation and increased cell survival
2000
Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray
2003 Standout
Arginine Methylation of STAT1 Modulates IFNα/β-Induced Transcription
2001
Cytokine Signaling in 2002
2002 Standout
Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy
2016 StandoutNobel
Novel disease targets and management approaches for diffuse large B-cell lymphoma
2010
Prognostic clinicopathologic factors, including immunologic expression in diffuse large B‐cell lymphomas
1999
Four versus six courses of a dose‐escalated cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen plus etoposide (megaCHOEP) and autologous stem cell transplantation
2005
STATs: transcriptional control and biological impact
2002 Standout
Prognostic Significance of Ki-67 Nuclear Proliferative Antigen, bcl-2 Protein, and p53 Expression in Follicular and Diffuse Large B-Cell Lymphoma
2001
Prevention of High-Dose Chemotherapy–Induced Cardiotoxicity in High-Risk Patients by Angiotensin-Converting Enzyme Inhibition
2006 Standout
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
2003 Standout
Prognostic significance of bcl-2 protein expression in aggressive non- Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)
1996
Three parameter flow cytometric analysis for simultaneous detection of cytokeratin, proliferation associated antigens and DNA content
1995
Follicular Helper CD4 T Cells (TFH)
2011 Standout
The revised International Prognostic Index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP
2006 Standout
Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma
2006
Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphoma.
2002
Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression.
1997
Risk-assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for Lymphomas.
2001
Infiltration of effector regulatory T cells predicts poor prognosis of diffuse large B-cell lymphoma, not otherwise specified
2017
Current status of cytogenetic research in childhood acute lymphoblastic leukemia
1993
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Organoselenium and Organotellurium Compounds: Toxicology and Pharmacology
2004 Standout
Prognostic significance of bcl-2 protein expression in aggressive non- Hodgkin's lymphoma. Groupe d'Etude des Lymphomes de l'Adulte (GELA)
1996
Works of RM Braziel being referenced
Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial
1994
Methylthioadenosine phosphorylase deficiency in acute leukemia: pathologic, cytogenetic, and clinical features
1988
Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial
1994